Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CDTOX A OIA

K-Number: K991829 · 1999-11-02

ApplicantBiostar, Inc.
Decision Date1999-11-02
Product CodeLLH
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CDTOX A OIA is the device name listed in this FDA 510(k) record. The listed applicant is Biostar, Inc.. It received FDA 510(k) clearance on 1999-11-02 under 510(k) number K991829. The device is classified under product code LLH. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CDTOX A OIA?

CDTOX A OIA is a medical device that received FDA 510(k) clearance on 1999-11-02. The listed applicant is Biostar, Inc.. The 510(k) number is K991829.

When did CDTOX A OIA receive FDA 510(k) clearance?

CDTOX A OIA received FDA 510(k) clearance on 1999-11-02, under 510(k) number K991829.

Who is the listed applicant for CDTOX A OIA?

The FDA 510(k) record lists Biostar, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CDTOX A OIA?

The FDA product code for CDTOX A OIA is LLH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Biostar, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑